NCT02758769View on ClinicalTrials.gov

Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings

CompletedOBSERVATIONAL
Enrollment

303

Participants

Timeline

Start Date

June 7, 2016

Primary Completion Date

November 15, 2023

Study Completion Date

November 15, 2023

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

ORENCIA Subcutaneous Injection

Trial Locations (2)

1070052

Local Institution - 0001, Minato-ku

Local Institution, Minato-ku

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY